RxDoctor Payments Data

Rakesh Chandra, MD

Otolaryngology · Nashville, TNNPI 1255389623

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $278,572 of the $380,907 with a category attached, or 73.1%. 24 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 47.5% of the total. 2025 is the largest year on record at $118,600, 5.5 times the $21,727 reported in 2019. Among otolaryngology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$380,907in general payments, 2019–2025

Across 394 payments — averaging $966.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$181K
  • Sanofi$141K
  • Optinose US, Inc.$17K
  • Gyrus ACMI, Inc.$11K
  • GSK$7K
  • Bristol Myers Squibb$5K
  • plus $18K from 18 others
$155,981in research payments, 2019–2025

Across 21 payments — averaging $7427.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aerin Medical Inc.$140K
  • Cumberland Pharmaceuticals, Inc.$16K

What the payments were for

  • Consulting fees$61,32516%
  • Speaking & faculty fees$278,57273%
  • Travel & lodging$25,5427%
  • Food & beverage$15,4684%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$380,907 in reported general payments places this provider in the 95th percentile of 191 otolaryngology providers in Tennessee.

See all otolaryngology providers in Tennessee

Medicare billing

Part B allowed, 2024
$92,921
Medicare patients
217
Services billed
665

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide40$1,171
Azelastine Hcl40$1,039
Fluticasone Propionate38$440
Doxycycline Monohydrate19$426
Mupirocin16$123

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →